Shows
Rare Disease DiscussionsConsider Rare: Suspecting and Diagnosing Hereditary Angioedema (HAE)Hereditary angioedema (HAE) is a rare condition often due to reduced levels C1-inhibitor, which is a protein involved in various physiological processes in plasma, most notably with the complement system. C1-inhibitor also binds and inhibits plasma kallikrein and factor XIa, thereby affecting bradykinin production. It is believed that the disruptions of these processes cause fluid to leak from the blood to connective tissue, leading to HAE attacks. Owing to its rarity, HAE is often poorly recognized, leading to misdiagnoses and significant diagnostic delays. Being aware of the early signs and symptoms of this condition can lead to faster...2025-03-0724 min
All Things Angioedema – Learning about angioedema with Dr. Thomas ButtgereitEpisode 33 – Comorbidities in people with HAEWhat comorbidities are seen in people with HAE? Dr Linda Sundler Björkman joins Dr Thomas Buttgereit to discuss her research on comorbidities in HAE, including methodology, key findings, and the need for further research.Disclosure statement: Unrestricted research grant from CSL Behring. Honorars from Takeda, Biocryst and CSL Behring.Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.Feedback form ATA: https://forms.office.com/e/ZWxx3D4Cmr2025-03-0423 min
IG Living Advocate PodcastA Patient’s Story: See the Difference Maintaining Steady Ig Levels Can Make in PIThis podcast is sponsored by CSL Behring, manufacturer of Hizentra, subcutaneous immune globulin. In this episode, we will discuss Melaine's journey with PI, from her experience with IVIG, to her switch to subcutaneous IG, and what that meant in terms of self-administering her treatment at home. Melaine enjoys cycling, gardening, travel and she's also living with primary immunodeficiency or PI. Melaine will be sharing her story and also providing some information about Hizentra, for which she is a patient advocate. Patient advocates are not healthcare professionals or medical experts. For medical questions or advice, please contact...2025-01-2820 min
allergytalkPediatric Hereditary Angioedema (HAE) Diagnosis & Management: Challenges, Barriers, Strategies miniseries Episode 3 – Long-Term Management and Prophylaxis for HAEHost: Kristin C. Sokol, MD, MS, MPH, FACAAI
Experts: Aleena Banerji, MD; Jonathan A. Bernstein, MD, FACAAI
Explore the strategies for long-term prophylaxis in pediatric HAE, including when to initiate treatment and the risks and benefits of various approaches. Transitioning care from childhood into adolescence and beyond is also discussed.
Learning Objective:
After listening to this podcast episode, participants should be better able to:
Employ strategies for long-term prophylaxis.
References:
Allen Meadows, MD; John Anderson, MD; Richard G. Gower, MD. Challenges in the management of...2024-12-1312 minallergytalkPediatric Hereditary Angioedema (HAE) Diagnosis & Management: Challenges, Barriers, Strategies miniseries Episode 2 – Overcoming Barriers in HAE TreatmentEpisode 2: Overcoming Barriers in HAE Treatment
Host: Kristin C. Sokol, MD, MS, MPH, FACAAI
Experts: Jonathan A. Bernstein, MD, FACAAI; Timothy J. Craig, DO, FACAAI
This episode addresses the challenges of managing HAE, including treatment differences in rural vs. urban settings, barriers to care, and the importance of shared decision-making for treatment plans. Discover effective strategies for on-demand home therapy administration.
Learning Objective:
After listening to this podcast episode, participants should be better able to:
Create effective treatment plans for their specific pop...2024-12-1320 minallergytalkPediatric Hereditary Angioedema (HAE) Diagnosis & Management: Challenges, Barriers, Strategies Miniseries Episode 1 – Diagnosing HAE AccuratelyHost: Kristin C. Sokol, MD, MS, MPH, FACAAI
Experts: Aleena Banerji, MD; Timothy J. Craig, DO, FACAAI
This discussion covers the key factors in accurately diagnosing HAE, including clinical history, lab testing, and the role of genetic testing in distinguishing between HAE types. Special considerations for diagnosing pediatric patients will also be discussed.
Learning Objective:
After listening to this podcast episode, participants should be better able to:
Diagnose pediatric HAE accurately
References:
Allen Meadows, MD; John Anderson, MD; Richard G. Gower, MD. Challenges in the management of hereditary...2024-12-1316 min
Market Access MattersExploring value demonstration in market access with Korinna Karampampa, CSL BehringKorinna Karampampa, who is Director Market Access and Pricing at CSL Behring, joins this episode to share her views on sustainable economic development. Korinna shares what led her into market access and explains what drives her to think outside the box to build and demonstrate a product's current and future value. The opinions shared in this episode are Korinna’s own views and not representative of the organisation she is working for. Send us a text2024-09-2614 min
Sourcing Industry LandscapeEmbracing Empathy in Procurement with Dupree Jones from CSL BehringIn this episode of the Sourcing Industry Landscape Podcast, host, Dawn Tiura welcomes Dupree Jones from CSL Behring. Dupree brings over 20 years of experience in global procurement, government contracts, and vendor management, with a career that spans from managing subcontractors in Iraq to leading transformations in various industries including aerospace, retail, and pharmaceuticals. Dupree shares insights on the importance of empathy in procurement and sales. He discusses the benefits of understanding the perspectives of both buyers and suppliers, especially during challenging times like the COVID-19 pandemic. Dupree emphasizes the need for thorough research and preparation in negotiations...2024-08-0519 min
PeerView Clinical Pharmacology CME/CNE/CPE VideoTruman J. Milling Jr., MD, FACEP - Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related BleedingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GRP865. CME credit will be available until November 8, 2024.Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related Bleeding In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph...2023-11-0850 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastTruman J. Milling Jr., MD, FACEP - Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related BleedingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GRP865. CME credit will be available until November 8, 2024.Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related Bleeding In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph...2023-11-0850 min
PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastTruman J. Milling Jr., MD, FACEP - Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related BleedingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GRP865. CME credit will be available until November 8, 2024.Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related Bleeding In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph...2023-11-0850 min
PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastTruman J. Milling Jr., MD, FACEP - Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related BleedingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GRP865. CME credit will be available until November 8, 2024.Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related Bleeding In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph...2023-11-0850 min
EMJ GOLD: Pharma marketing, medical & moreS05 E06: Meet GOLD’s new catalyst – CSL Behring’s Karen Pinachyan In this week’s episode, Isabel and Jade share some snippets from the interview with GOLD’s next catalyst Karen Pinachyan, Head of Medical Affairs, Europe, CSL Behring. In this teaser edition of the full interview, Karen shares his motivation for joining the pharmaceutical industry, his thoughts on how to shift the care paradigm towards personalised medicine and how he believes both industry and healthcare systems can work together to deliver more value to patients. 2023-07-1114 min
World of PromiseWorld of Promise Rare Disease Day with Dr Ala Stanford March 2023 Dr. Ala Stanford has a long list of accomplishments. She is the first black female pediatric surgeon trained entirely in the United States. She is the founder of the Black Doctors COVID-19 Consortium. She opened the Ala Stanford Center for Health Equity in 2021 to offer primary care and behavioral health services in North Philadelphia. In 2022, USA Today named her to their list of Women of the Year, and she was appointed as Regional Director for the U.S. Department of Health and Human Services. In November 2020, CSL announced a collaboration with the Urban League of Philadelphia focusing...2023-03-1427 min
The New Horizon TalksEpisode 7: Improving Equity in Patient Access to Specialised Care and Treatments through the European Reference NetworksTo mark Rare Disease Day 2023 focused on “equity”, the New Horizon Talks turn to European initiatives which can effectively contribute to fostering equity in patients’ access to diagnosis, specialised care and treatment for rare diseases. This episode explores the role of European Reference Networks (ERNs), with a specific focus on the ERN on rare hematological diseases (EuroBloodNet). Speakers discuss achievements to date, remaining challenges, and how new policy frameworks and multi-stakeholder partnerships can help strengthen the ERNs.
Guests:
Victoria Hedley, Rare Disease Policy Manager, Newcastle University
Prof. Cédric Hermans, Head Haemostasis and Thrombos...2023-02-2328 min
World of PromiseCelebrating Rare Disease Day with Jodi Taub On Feb. 28, Rare Disease Day recognizes and celebrates the more than 300 million people around the world living with one of more than 7,000 rare diseases. In honor of Rare Disease Day, the World of Promise podcast hosts a special guest this month. Jodi Taub is a therapist based in New York City with more than 24 years of field-based experience treating an array of mental health and emotional issues. She is a Licensed Clinical Social Worker with experience working with children and families, and she lives with Primary Immunodeficiency. Among the topics that Taub discusses with World...2023-02-1622 min
The New Horizon TalksEpisode 6: Leveraging Real World Evidence for Advanced TherapyThis episode explores how real-world evidence is changing healthcare, its value in improving patients’ outcomes, its role in supporting R&D in advanced therapy and uptake of this innovation by health systems. It will discuss issues such as how to deal with evidence gaps in HTA and the role of RWE. It will reflect on the importance of the European Health Data Space in leveraging RWE collected in Europe and its benefits for rare disease patients. It will also look at how to ensure that health data is efficiently leveraged to help the development of advanced therapy in a su...2022-10-2720 min
World of PromiseHow Project Healing Waters Serves Veterans and Current Military, an interview with David FolkertsProject Healing Waters Fly Fishing is a nonprofit organization whose mission is to use the sport of fly-fishing and associated activities as a means of physical and emotional recovery for disabled veterans and wounded, injured and ill military service members. In 2020, some employees at CSL Behring formed a partnership with this organization. On this episode, Project Healing Waters Chief Operations Officer and U.S. Army veteran David Folkerts talks about the program’s mission, how it supports veterans and current military service members, and how you could get involved if this sounds like a program you’d like to be p...2022-09-2026 min
The New Horizon TalksEpisode 5: Advancing Europe's leadership in rare disease innovationThis episode explores the EU’s leadership in response to rare diseases and innovation in the area, with a special focus on advanced therapy research and development. What are the achievements made in Europe and where are the remaining gaps? How can Europe achieve leadership in innovation for rare diseases?
Guests:
Yann Le Cam, CEO, EURORDIS
Elisabetta Zanon, Director, EU Public Affairs & Advocacy, Alliance for Regenerative Medicine, Europe2022-09-2023 min
The Mary Mavis ShowForging Your Career PathWhat does "career" mean to you? How has it changed? And how should we think about our career path or journey? These are questions I talk with my two guests who are mother and daughter.Deirdre BeVard is the Senior Vice President of R&D Strategic Operations for CSL Behring, a global pharmaceutical company. She has the accountability for CSL’s clinical trials, project management, patient relationships, trial enabling technology across six therapeutic areas—and she leads CSL’s operations in China and Japan. Including CSL, Deirdre has had thirty years of experience in numerous clinica...2022-09-0547 min
The Data Storytellers PodcastBridging Technology and Medicine through Advanced Analytics | Nitin Bhatnagar (Senior Director of Global Commercial Insights and Analytics at CSL Behring)On this episode of The Data Storytellers podcast, we discuss the transformative impact of data, technology, and human capital in the pharmaceutical sector with Nitin Bhatnagar, Senior Director of Commercial Global Insights and Analytics at CSL Baring. Nitin shares his extensive experience in integrating data-driven strategies within healthcare, emphasizing how analytics not only refines drug development and market strategies but also enhances patient outcomes. Our conversation highlights the importance of cross-functional collaboration, the strategic use of data in overcoming industry challenges, and the ethical considerations essential in deploying AI and machine learning in healthcare.Connect with us:2022-08-2530 min
Diabetes Knowledge into Practice PodcastFocus on CKD: Latest guidelines and therapies | With Dr David CherneyThe last two years have provided updated guidelines on management of chronic kidney disease in type 2 diabetes alongside new regulatory approvals of pharmacotherapies. In this episode we speak to Dr David Cherney about the implications of these updates and advancements.
By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at https://diabetes.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources.
References available here
Disclosures:
2022-08-2218 min
BloodStreamA women’s movement’s a brewin’There is a women’s movement a brewin’ and Patrick & Amy have the scoop! Special guest Ashley Gregory is here to tell us all about it! Plus, Amy has a diagnosis of her own to talk about, and Jessica brings us back to The Well for a segment on growth featuring community member, Michelle Conde. Presenting Sponsor: Takeda (bleedingdisorders.com) Episode Advertiser: CSL Behring (portraitsofprogress.com) Learn more about FAIR! Contact ashley.gregory@hemofoundation.org. Show Notes: Presenting Sponsor: Takeda. Visit bleedi...2022-08-1245 min
The New Horizon TalksEpisode 5: Advancing Europe’s leadership in rare disease innovation (Bonus edition)This episode explores EU’s leadership in response to rare diseases and innovation in the area, with a special focus on advanced therapy research and development. What are the achievements made in Europe and where are the remaining gaps? How can Europe achieve leadership in innovation for rare diseases? The bonus edition provides insights about the impact of the COVID-19 pandemic on rare disease patients and innovation in the field.
Guests:
Yann Le Cam, CEO, EURORDIS
Elisabetta Zanon, Director, EU Public Affairs & Advocacy, Alliance for Regenerative Medicine, Europe2022-08-1119 min
ANA InvestigatesANA Investigates Updates in Autoimmune Encephalitis, part 2, therapeutics Last month on the podcast, we talked about updates in the diagnosis of autoimmune encephalitis. This month we turn to advances in the treatment of autoimmune encephalitis. Treating these conditions has traditionally been practitioner-dependent, and currently no FDA-approved therapies exist. But that’s beginning to change. Series 3, Episode 9. Featuring: Guest: Dr. Maarten Titulaer, Erasmus MC University Medical Center Interviewer/Producer: Dr. Rohini Samudralwar, University of Pennsylvania Disclosures: Dr. Titulaer disclosed that his institution receives consulting funds form UCB, Viela Bio (Horizon), and CSL Behring, he is the co-investigator on the ExTinguish trial funded in part by Horizon, and a...2022-07-2620 min
YB-PodcastWankdorf-PodcastIm Zusammenspiel mit Stadionpartner CSL Behring wird das erste Heimspiel der Saison gegen den FCZ unter dem Motto "Wankdorf" ausgetragen. Zur Einstimmung auf das Spiel veröffentlicht der BSC YB einen besonderen "Wankdorf-Podcast" – präsentiert von CSL Behring.
In der Ausgabe kommen prominente Gäste zu Wort: So spricht YB-Trainer Raphael Wicky über seine Laufbahn und seinen Bezug zum Wankdorf. Und YB-CEO Wanja Greuel erklärt gemeinsam mit CSL Behring-Chefin Livia Artuso, weshalb das Stadion heute überhaupt wieder Wankdorf heisst und wie die Partnerschaft entstanden ist.
Auch wenn es sich um eine einmalige Podcast-Folge handelt, dürfen sich die YB-Fans künftig a...2022-07-131h 22BloodStreamRare Disease Podcasters on Patient-Centricity and a new segment of The Well!Patrick and Amy are joined by three of the most prolific and committed rare disease podcasters out there: Effie Parks from Once Upon A Gene, Kyle Bryant from Two Disabled Dudes, and Bo Bigelow from Stronger Every Day. Those three titans behind the mic join us for a candid discussion about patient centricity, we touch on some recent news, FLOW’s Jessica Lauren Richmond is back with the latest installment of The Well. Show Notes: Subscribe to: Once Upon a Gene 2DD Stronger Everyday Re...2022-06-101h 13
World of PromiseWorld Hemophilia Day and Expanding Access to Therapies for People with Bleeding DisordersMegan Adediran, President of the Hemophilia Foundation of Nigeria and Durhane Wong-Rieger, President and CEO of the Canadian Organization for Rare Disorders, join the podcast to talk about the importance of finding new and innovative ways to expand access to life-saving therapies for people living with bleeding disorders. 2022-04-1318 min
World of PromiseWhen’s the Right Time to Tell that Special Someone About Your Rare Disease?When it comes to dating and starting a new romantic relationship, people who live with rare and serious diseases face some unique questions. When is the right time to tell that special person about my condition? And how do you bring the topic up to a potential romantic partner? On a new episode of the World of Promise podcast, host Anthony Farina sat down with two experts to talk about this topic. Joining Anthony was Dr. Nancy Irwin, a Los Angeles-based clinical psychologist and author who has appeared on television shows such as “The Doctors” and “Anderson Live” w...2022-02-2513 min
World of PromiseListen: The Future of Flu VaccinesOn a new episode of World of Promise, host Anthony Farina is joined by Stefan Merlo, Vice President of Commercial Development at Seqirus, and Roberta Duncan, the vaccine company's Vice President, mRNA Program Lead, to discuss what’s next in terms of flu vaccine technology. They discuss the potential of aQIVc flu vaccine technology as well as sa-mRNA and how it differs from other mRNA vaccines.2021-12-1516 min
The New Horizon TalksEpisode 4: Taking the Ethical Debate ForwardThis conversation takes a deep dive into the ethical issues surrounding cell and gene therapies. What are the main questions from patients and the broader public? What are the key myths surrounding these therapies? It explores topics such as transparency, responsibility in science and research efforts, inclusivity & non-discrimination in access.
Guest:
Hervé Chneiweiss, Chairman, INSERM Ethics Committee; Chair, UNESCO International Bioethics Committee; member, WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing
2021-10-1925 min
The New Horizon TalksEpisode 3: Advancing For and With PatientsThis podcast examines patient centricity in cell and gene therapy, exploring how care must be planned and delivered to be responsive to individual patient preferences, needs and values. What exactly does patient focus mean, when talking about advanced therapies? What should patients know before embarking on the therapy and how do patient advocacy organisations support patients in this process?
Guest:
· Durhane Wong-Rieger, Chair, Rare Disease International Council
----
Abbreviations:
· HTA: Health technology assessment
· ERNs: European reference networks2021-10-0628 min
Data Science LeadersExploring the Future of Data: Regulations & Managing Analytics Teams (John Thompson, Global Head of Advanced Analytics & AI, CSL Behring)Between GDPR, CCPA, and more regulatory frameworks on the horizon, the landscape of personal data—and how it can be used in business—is shifting.On this episode, John Thompson, Global Head of Advanced Analytics & AI at CSL Behring, joins host Dave Cole to discuss that shift, and a potential future in which we as individuals could be compensated for the use of our data.Plus, John shares the two types of analytics teams he’s seen work well during his career as a data science leader.Topics covered include:- If and how individuals can know w...2021-09-2845 min
The New Horizon TalksEpisode 2: Transforming the Future of Healthcare TogetherIn this episode, we look at the unique policy challenges presented by cell and gene therapies from research & development through to patient access; and the role of multi-stakeholder collaborations, in particular those active in supporting European policymaking. How can we, together, deliver these innovative therapies to patients and society, efficiently and safely?
Guests:
• Amanda Bok, Chief Executive, European Haemophilia Consortium (EHC)
• Alexander Natz, CEO, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
----
Abbreviations:
• ATMPs: Advanced therapy medicinal products
• EBMT: European Society for Blood and Marrow Transplantation
• G...2021-09-2728 min
The New Horizon TalksEpisode 1: New Horizons for Rare Disease PatientsThis episode provides an introduction to cell and gene therapies and touches upon the historical, scientific, clinical, policy and regulatory considerations surrounding their development and use, with forward-looking perspectives from our guests on the future of this new chapter of medicine.
Guests:
· Professor Luigi Naldini, Director, San Raffaele Telethon Institute for Gene Therapy
· Avril Daly, Vice-president, Rare Diseases Europe (EURORDIS); CEO, Retina International
----
Abbreviations:
· CAR T cells: chimeric antigen receptor T cells
· HTA: Health technology assessment2021-09-2228 min
The New Horizon TalksBonus episode: Advancing For and With PatientsThis podcast examines patient centricity in cell and gene therapy, exploring how care must be planned and delivered to be responsive to individual patient preferences, needs and values. What exactly does patient focus mean, when talking about advanced therapies? What should patients know before embarking on this therapy and how do patient advocacy organisations support patients in this process?
Guest:
• Durhane Wong-Rieger, Chair, Rare Disease International Council
Abbreviations:
· HTA: Health Technology Assessment
· ERNs: European Reference Networks2021-08-2719 min
World of PromiseThe Importance of Pandemic PreparednessCOVID-19 has offered the biotech industry many lessons. Among the lessons that stands out to Lorna Meldrum is the importance of being prepared for both seasonal flu and the potential for a pandemic outbreak. Meldrum is Vice President of Commercial Operations, International Markets and Pandemic at Seqirus, one of the world’s leading influenza vaccine producers, and she’s the latest guest on the World of Promise podcast. During her conversation with host Anthony Farina, Meldrum discusses the challenges businesses have faced during the pandemic and how Seqirus is continuing to expand its seasonal and pand...2021-08-1615 min
Event Design Collective PODcastsPierre MacNeil - BACKSTAGE - Designer Series - CSL Behring Asia Pacific On Claiming TimeRuud Janssen of the Event Design Collective is having a conversation with Pierre MacNeil on his views and experiences in using Event Design using the #EventCanvas with his team at CSL Behring Asia Pacific and how it relates with Pierre's experience as an event owner in his biopharmaceutical career.
Pierre MacNeil is Head, Commercial Excellence and Customer Engagement, Asia Pacific at CSL Behring based in Hong Kong.
As a global healthcare executive with broad commercial experience including health policy shaping and market access he thrives while team-solving high stake, high pressure, complex business challenges. By leveraging data sciences and machine...2021-07-2820 min
Event Design Collective PODcastsPierre MacNeil - ONSTAGE - Designer Series - CSL Behring Asia Pacific On Claiming TimeRuud Janssen of the Event Design Collective is having a conversation with Pierre MacNeil on his views and experiences in using Event Design using the #EventCanvas with his team at CSL Behring Asia Pacific and how it relates with Pierre's experience as an event owner in his biopharmaceutical career.
Pierre MacNeil is Head, Commercial Excellence and Customer Engagement, Asia Pacific at CSL Behring based in Hong Kong.
As a global healthcare executive with broad commercial experience including health policy shaping and market access he thrives while team-solving high stake, high pressure, complex business challenges. By leveraging data sciences and machine...2021-07-2820 min
World of PromiseThe Safety of VaccinesAmidst the development and rollout of COVID-19 vaccines around the globe, conversations around vaccine safety are at an all-time high. On a new episode of the World of Promise podcast, Gregg Sylvester, Chief Medical Officer and Head of Medical Affairs for leading vaccine producer Seqirus, sits down with host Anthony Farina to discuss how Seqirus ensures that its vaccines are safe – the processes that are implemented and why this topic is so important to an organization on the front lines to protect public health.2021-06-2409 min
World of PromiseHow Technology is Changing VaccinesInnovation was key to creating effective vaccines in the fight against COVID-19. Now, those innovations are being studied for the creation of leading edge influenza vaccines, explains Ethan Settembre, VP, R&D for Seqirus. He talks about how Seqirus is leveraging existing cell and adjuvant technology to deliver effective vaccines and exploring the combination of the two in aQIVc, the company’s next pipeline vaccine. Ethan also speaks to self-amplifying mRNA, the next-generation mRNA platform Seqirus is evaluating for influenza.2021-05-2715 min
Podcast de Perguntas & Respostas do WebinarPerguntas & Respostas: Webinar CSL Behring: Dra. Roseny dos Reis Rodrigues - CompletoWebinar Estratégias para implementação do protocolo de reversão de anticoagulantes antagonistas de vitamina K, nele eu entrevisto a Dra. Roseny dos Reis Rodrigues - Completo2021-05-1118 minPodcast de Perguntas & Respostas do WebinarIntrodução - Webinar Estratégias para implementação do protocolo de reversão de anticoagulantes antagonistas de vitamina K, nele eu entrevisto a Dra. Roseny dos Reis Rodrigues.Introdução Webinar Estratégias para implementação do protocolo de reversão de anticoagulantes antagonistas de vitamina K, nele eu entrevisto a Dra. Roseny dos Reis Rodrigues.2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 01 - Dra, no Hospital onde a sra atua e implementou o protocolo, quanto tempo decorreu entre você abordar e sensibilizar os envolvidos até efetivamente conseguir implementar o protocolo?Dra, no Hospital onde a sra atua e implementou o protocolo, quanto tempo decorreu entre você abordar e sensibilizar os envolvidos até efetivamente conseguir implementar o protocolo?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 02 - Vale à pena ter na sala de emergência o CCP para uma rápida abordagem nos casos de pacientes em uso de antagonistas da Vitamina K e que dão entrada com quadros graves de hemorragia maiorE vale a pena ter na sala de emergência o CCP para uma rápida abordagem nos casos de pacientes em uso de antagonistas da Vitamina K e que dão entrada com quadros graves de hemorragia maior?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 03 - A reversão com concentrado de complexo protrombínico, é imediata, Dra? Em quanto tempo já consigo observar a ação desse medicamento?A reversão com concentrado de complexo protrombínico, é imediata, Dra? Em quanto tempo já consigo observar a ação desse medicamento?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 04 - Não seria interessante definir uma proporção para transfusão maciça em trauma? Se fazemos plasma indiscriminadamente porque não fazer concentrado de complexo protrombínico mesmo sem tromNão seria interessante definir uma proporção para transfusão maciça em trauma? Se fazemos plasma indiscriminadamente porque não fazer concentrado de complexo protrombínico mesmo sem tromboelastografia ou ROTEM?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 05 - Poderia abordar a questão de custo entre plasma fresco congelado e concentrado de complexo protrombínico?Poderia abordar a questão de custo entre plasma fresco congelado e concentrado de complexo protrombínico?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 06 - Um participante comentou durante o webinar que ele trabalha com cirurgia cardíaca e utiliza o ROTEM quando disponível, porém a bula do CCP informa a meta pelo INR. Ele pergunta qual doseUm participante comentou durante o webinar que ele trabalha com cirurgia cardíaca e utiliza o ROTEM quando disponível, porém a bula do CCP informa a meta pelo INR. Ele pergunta qual dose deve utilizar nesse caso e se ele pode utilizar como dose 25 UI por Kg.2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 07 - O concentrado de complexo protrombínico já existe em larga escala para uso no mercado e no cenário hospitalar?O concentrado de complexo protrombínico já existe em larga escala para uso no mercado e no cenário hospitalar?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 08 - Qual é a duração de ação do CCP? Existe alguma situação que devemos repetir a dose?Qual é a Duração de ação do CCP? Existe alguma situação em que devemos repetir a dose?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 09 - Há indicação de fazer complexo protrombínico profilático em cirurgias eletivas? Se sim, em qual situação?Há indicação de fazer complexo protrombínico profilático em cirurgias eletivas? Se sim, em qual situação?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 10 - Na prática clínica após a implementação do protocolo você observou redução da mortalidade?Na prática clínica após a implementação do protocolo você observou redução da mortalidade?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 11 - Em sua experiência, existe risco de trombose no uso do concentrado de complexo protrombínico?Em sua experiência, existe risco de trombose no uso do concentrado de complexo protrombínico?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 12 - Há alguma situação do uso de vitamina K junto com o concentrado de complexo de protrombínico?Há alguma situação do uso de vitamina K junto com o concentrado de complexo de protrombinico?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 13 - Em casos de sangramanto intra operatório, sem uso de cumarínicos, tem indicação a utilização de concentrado de complexo protrombínico?Em casos de sangramanto intra operatório, sem uso de cumarínicos, tem indicação a utilização de concentrado de complexo protrombínico?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 14 - É autorizado realizar bloqueio de neuroeixo após a reversão do anticoagulante antagonista de vitamina K com complexo protrombínico?É autorizado realizar bloqueio de neuroeixo após a reversão do anticoagulante antagonista de vitamina K com complexo protrombínico?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 15 - Existe algum manuseio diferenciado do uso de concentrado de complexo protrombínico para os pacientes com insuficiência renal não dialítico?Existe algum manuseio diferenciado do uso de concentrado de complexo protrombínico para os pacientes com insuficiência renal não dialítico?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 16 - Após o uso do CCP há segurança para cateter de peridural?Após o uso do CCP há segurança para cateter de peridural?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 17 - Nos pacientes em ECMO, alguns serviços não usam o CCP, mas sim o plasma guiado pelo ROTEM. Essa prática é devida à preocupação de maior risco de trombose? Seria essa sua conduta?Nos pacientes em ECMO, alguns serviços não usam o CCP, mas sim o plasma guiado pelo ROTEM. Essa prática é devida a preocupação de maior risco de trombose? Seria essa sua conduta?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarPergunta 18 - Qual a sua opinião sobre uso de CCP em pacientes no intraoperatório de cirurgia cardíaca em recém-nascidos, considerando-se a fisiologia do sistema hemostático nessa idade?Qual a sua opinião sobre uso de CCP em pacientes no introperatório de Cirurgia cardíaca em recém-nascidos, considerando-se a fisiologia do sistema hemostático nessa idade?2021-05-1100 minPodcast de Perguntas & Respostas do WebinarPergunta 19 - Quais foram seus maiores obstáculos para a implementação e continuidade do protocolo de reversão nas instituições?Quais foram seus maiores obstáculos para a implementação e continuidade do protocolo de reversão nas instituições?2021-05-1101 minPodcast de Perguntas & Respostas do WebinarEncerramento – Perguntas & Respostas da webinar “Estratégias para implementação do protocolo de reversão de anticoagulantes antagonistas de vitamina K”.Por hoje ficamos por aqui, gostaria de agradece-los por ouvir nosso podcast! Para assistir na íntegra o webinar Estratégias para implementação do protocolo de reversão de anticoagulantes antagonistas de vitamina K acesse www.connectingminds.com.br”
Caso tenha dúvidas sobre o uso, manuseio e administração do Beriplex (concentrado de complexo protrombínico) fique à vontade para entrar em contato com nossos representantes de vendas!
Obrigado e até o próximo podcast!2021-05-1100 min
World of PromiseAdapting to Change: World Hemophilia Day 2021The theme for this year’s World Hemophilia Day on April 17 is “Adapting to Change.” The day raises awareness for hemophilia and other bleeding disorders. This episode features Dr. Glenn Pierce, Vice President, Medical, for the World Federation of Hemophilia and Dr. Roshni Kulkarni, professor and former Director of Michigan State University’s Center for Bleeding and Clotting Disorders. They talk about changes in hemophilia and bleeding disorder treatments and how this past year has changed everything.2021-04-0820 min
World of PromiseTaking Risks, Overcoming Doubts: Two Top Biotech Leaders Share Their Experiences and Offer Career Advice in Honor of Women's History MonthIn honor of Women's History Month, this episode features two CSL leaders. Karen Neave, Senior Vice President and Chief Risk Officer, and Antje Michel, General Counsel, share their career journeys, the obstacles they've overcome and offer advice for other women working in biotechnology. During the 20-minute conversation, they also offer insights into how they achieved success and work/life balance, particularly in today’s COVID-19 remote working environment.2021-03-2921 min
World of PromiseThe Case for Career Development: CSL's Chief Human Resources Officer Explains Why the Biotechnology Company Wants Employees to Invest in ThemselvesTo thrive in the fast-moving field of biotechnology, embrace learning and career development, Elizabeth Walker, Executive Vice President and Chief Human Resources Officer for CSL, says on a this episode. As head of human resources for one of the world’s largest biotechnology companies, Walker said employee development remains a priority. “It benefits – not only the individual – but CSL as well,” she says. “Over time we have seen other organizations pull back on investments in this area and shift the burden of development entirely to employees. We think that's a mistake. We think development has many benefits. It helps to...2021-03-0307 min
World of PromiseThe Connection Between Influenza and COVID-19In 2020, COVID-19 dominated the headlines and much of the focus for people who work in biotechnology. While the global pandemic continues, there is hope in the vaccines currently being distributed throughout the world. At the same time, seasonal influenza remains a concern. On a new episode of the World of Promise podcast, Dave Ross, Vice President, Commercial Operations North America, for Seqirus, discusses how his organization’s expertise in influenza vaccines could help with the distribution and immunization practices necessary to combat COVID-19. He also shares additional insights from his team’s work with influenza and how it r...2021-01-2818 min
World of PromiseWhat Does Digital Transformation Mean for Rare Disease Patients?For more than 30 years, Mark Hill has worked in the digital technology space for large, global biotech and pharmaceutical companies. Now, he is Chief Digital Information Officer for CSL, the world’s third largest biotechnology company. On a new episode of the “World of Promise” podcast, Mark sits down with host Anthony Farina to chat about his experiences, what he’s learned and where he sees digital transformation taking biotechnology in the near and not-so-near future. As an Army veteran, Mark also talks about what military veterans can offer the biotech space, as well as how being the midd...2021-01-0518 min
East Meets West: A Podcast about understanding Asia Tech and how Asia Tech affects the worldCOVID-19 Vaccines and Plasma Therapy - How Healthy is CSL? (ASX:CSL)Every week we breakdown a company in a refreshingly simple way.
In this episode, Dan and Albert talk about CSL Limited. CSL is the one of largest global biotech companies in the world. It is listed on the Australian Securities Exchange and operates to deliver science therapies such as plasma-derived immunoglobulins for the treatment of immune deficiencies and neurological conditions, in its CSL Behring division, and influenza vaccines, in its Seqirus division.
In this episode we cover:
CSL's two business divisions, CSL Behring and Seqirus
How blood and plasma donations occur
What plasma-derived therapies...2021-01-0332 min
World of PromiseDiscussing the Increased Demand for Flu Vaccines in 2020On this episode of "World of Promise," host Anthony Farina interviews Steve Marlow, General Manager of Seqirus, one of the world's leading flu vaccine businesses. Steve also has 20 years of experience in biotech and he talks about the increased demand for flu vaccines during this year's Northern Hemisphere flu campaign. 2020-11-1311 min
World of PromiseMarking International Plasma Awareness Week with CSL Plasma's Willy Pardinas This week is International Plasma Awareness Week, and in honor of the week, Willy Pardinas, General Manager and Vice President of CSL Plasma sits down with “World of Promise” podcast host Anthony Farina to discuss the importance of plasma donation to people around the world living with rare and serious diseases. The conversation also touches on what a donor can expect during their first visit to a plasma center and the steps CSL Plasma centers take to protect donors during the COVID-19 pandemic.2020-10-0616 min
World of PromiseSuffering in Silence: Assessing Rare Disease Awareness and Management in Asia-Pacific - A Conversation with Jesse Quigley Jones of the Economist Intelligence UnitAround the globe, one of the biggest challenges rare disease patients face is getting a timely and accurate diagnosis of their condition. A new report by the Economist Intelligence Unit – the research and analysis division of the Economist Group and the world leader in business intelligence – takes a look at the challenges facing patients living with rare diseases across five Asia Pacific economies. Titled “Suffering in Silence,” the findings of the report have been published in a 9,000-word white paper that explores health care professionals’ understanding and management of rare diseases in Australia, China, Japan, South Korea and Taiwan...2020-07-2222 min
EmatologiaEmofilia e Value Based Health Care, l'esempio di CSL BehringIntervista a Oliver Schmitt, Amministratore Delegato di CSL Behring Italia2020-07-1305 min
Så sjuktAvsnitt 13: Donerad blodplasma räddar livBlodplasma från 130 donationer, från helt friska donatorer – ja, det är vad som krävs för en ganska vanlig årsförbrukning för att en person med primär immunbrist ska kunna få sin immunglobulinbehandling. I det här avsnittet tar vi reda på hur läkemedelstillverkningen och arbetet med att säkra tillgången på plasma går till. Vi träffar också Erik Ståhl igen – en av alla de som är beroende av människors vilja att donera blodplasma. Avsnittet avslutas med frågelådan och Anders Fasth. Övriga medverkande: Julia Nordin, IPOPI och Michael Grövdal, medicinsk chef CSL B...2020-06-1644 min
World of PromiseSuper Bowl MVP Santonio Holmes Discusses His Family's Battle Against Sickle Cell DiseaseSantonio Holmes is remembered for many things by football fans, including his “perfect catch” in Super Bowl XLIII, which earned him that game’s MVP trophy. But after retirement from football, Holmes is still working on building his legacy. He’s doing so through the III & Long Foundation, an organization he established to help families affected by Sickle Cell Disease. Holmes and his family are one of those families, as his son, TJ, lives with Sickle Cell Disease. On a new episode of the World of Promise podcast, Holmes, TJ, and TJ’s mom, Nicole King, talk...2020-06-1621 min
World of PromiseWhy Clinical Trials Are ImportantOn May 20, people who work in biotechnology celebrated Clinical Trials Day, a day that highlights the important role clinical trials play in developing therapies for our patients. This year, as the COVID-19 pandemic continues to impact people around the world, clinical trials are as important as ever. On a new episode of the World of Promise podcast, host Anthony Farina talks to Deirdre BeVard, CSL Behring’s Senior Vice President of R&D Strategic Operations, about clinical trials and how they benefit patients. Deirdre shares her perspective on why clinical trials are so critical to the advancement of...2020-06-0209 min
The Alldus Podcast - AI in ActionE90 John Thompson, Global Head of Advanced Analytics & AI at CSL BehringToday's guest is John Thompson, Global Head of Advanced Analytics & AI at CSL Behring, who are the third largest biopharmaceutical company in the world. They derive lifesaving therapies from human plasma: specializing in treating rare diseases such as hemophilia. John manages the global advanced analytics & AI team, who are responsible for building, deploying and maintaining the analytics applications and models for the global organization.
John is an accomplished operational executive who excels at building and managing innovative, growth-oriented data and technology organizations across multiple industries, with a recent focus on the healthcare and biopharmaceutical markets. John is a...2020-05-1925 min
TRENDSETTERSTRENDSETTERS: CSL’s Anthony Farina Urges Marketers “To Say What They Stand For”-- Especially Now…Anthony Farina is Chief Communications Officer & Global Corporate Affairs Leader at CSL Behring—now the world’s third-largest biotechnology leader. Earlier this month, CSL Behring announced the formation of a new alliance with Japan’s Takeda Pharmaceutical Company and other international partners to develop a potential plasma-derived therapy for treating COVID-19. He commented that “Unprecedented times call for unprecedented actions. This new alliance brings together the expertise of industry leaders worldwide for scale, sustainability, and reliability.”2020-04-2027 min
World of PromiseCelebrating 30-Plus Years of World Hemophilia Day with the World Federation of HemophiliaAs the COVID-19 pandemic continues around the world, rare disease patient groups continue to provide support and outreach to their communities. For the World Federation for Hemophilia (WFH), this year is an especially important one to mark World Hemophilia Day on April 17. “Particularly in light of what we’re all experiencing right now, I think the most important thing is that our global bleeding disorders community stays connected,” says Jennifer Laliberté, Director, Strategic and Community Partnerships for WFH on a new episode of the World of Promise podcast. She said celebrating World Hemophilia Day, which this year marks 3...2020-04-1422 min
World of PromiseBiotech Security Leader Shares Lessons Learned from COVID-19On this episode of World of Promise, host Anthony Farina talks to Tony Strickland, Head of Enterprise Security at biotech leader CSL Behring, about being on the front lines of company security during the COVID-19 pandemic. Strickland has been working to protect employees and patients from the Coronavirus since the outbreak in December. Strickland answers questions about what people can do to protect themselves and the lessons he has learned while working on the front lines to protect people from the global outbreak. 2020-03-3009 min
World of PromiseMeet a Doctor Who Chased His Own Rare Disease CureTwo days after David Fajgenbaum was diagnosed with Castleman’s Disease, a rare disorder that affects the lymph nodes, he was having his last rites read to him. A former quarterback at Georgetown University who was in medical school at the time of his diagnosis, Fajgenbaum began researching his own disease and remarkably, his research led to remission. Now, Fajgenbaum has published a book, "Chasing My Cure: A Doctor’s Race to Turn Hope into Action." On the latest episode of “World of Promise,“ Fajgenbaum discusses his story and how he is now living his life “in overtime."2020-02-1933 minWorld of PromiseThe "Palpable Passion" of Patient FocusPeople who work for biotech leader CSL Behring have a special passion for patient focus, explains the company’s Chief Medical Officer Charmaine Gittleson. “I think that people who work here within CSL – we care. That’s why we’re here,” she said during a recent interview with CSL’s Chief Communications Officer, Anthony Farina. The interview was featured on a recent episode of the CSL NOW Podcast, released internally for CSL employees.2020-01-2909 minWorld of PromisePaul McKenzie on Leadership, Innovation and the Future of BiotechAs Chief Operating Officer for the world’s fifth largest biotech company, CSL, Paul McKenzie has strong insights on what the future holds for the industry, innovation, and how leaders can best work on behalf of patients around the world. On this episode of "World of Promise," he sits down with host Anthony Farina to share his thoughts on these and other topics. 2019-09-2415 minWorld of PromiseUplifting Athletes: How Football Players Are Tackling Rare DiseasesIn the United States, football season is about to get underway. But for rare disease researchers, there is no off season. That’s why for Uplifting Athletes, raising awareness and funds in the fight against rare diseases is a year-round endeavor. Since the nonprofit organization consists of a national network of chapters run by current football student-athletes, the football season does have some special significance, however. That why on a new episode of the “World of Promise” podcast, host Anthony Farina was excited to sit down with Rob Long, Executive Director of Uplifting Athletes. “The...2019-08-2013 minWorld of PromiseGrowing Up with Sickle Cell Disease: One Patient's Experience and InsightOn this episode of "World of Promise," host Anthony Farina talks to Tahirah Austin, who is living with Sickle Cell Disease, about the challenges she faces, and has faced, as a person with the condition. The episode also features a segment from an expert on Sickle Cell Disease, who offers some additional advice for patients and also talks about what the future holds for people living with the condition.2019-06-1819 min
World of PromiseDo Something: A Conversation with Vicki and Fred Modell on the Jeffery Modell FoundationWhen Jeffrey Modell continually begged his parents to “do something” about his Primary Immunodeficiency, it broke their hearts. But Vicki said that she and her husband, Fred, saw their son’s words as an “impassioned plea.” In 1987, one year after Jeffrey’s death, the Modells founded a foundation in their son’s name. Since that time, the Jeffrey Modell Foundation has established a network of more than 800 expert physicians serving nearly 300 cities in 86 countries, spanning six continents. Indeed, the Modells have “done something.” The Modells story is the subject of a documentary being released on June 11 through all digital and vi...2019-05-2115 min
World of PromiseWorld Hemophilia Day and Von Willebrand DiseaseOn this episode of "World of Promise," Dr. Andra James of Duke University School of Medicine discusses Von Willebrand Disease, how it affects women and girls, and the promise of biotechnology to improve the lives of people with bleeding disorders. This episode also features Mary Ann Massolio, who is living with Von Willebrand Disease, and insights from Debbie Bensen-Kennedy of CSL Behring. 2019-04-1619 min
Neurology® PodcastSeptember 18 2018 Issue1. Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial2. What’s Trending: Emerging therapies for spinal muscular atrophy and Duchenne muscular dystrophyDr. Jeff Ratliff talks with Dr. Alberto Benussi about his paper on cerebellar anodal and spinal cathodal transcranial direct current stimulation as a therapeutic approach for reducing symptoms in patients with neurodegenerative ataxia. In the second part of the podcast, we are featuring a discussion with Dr. Ted Burns and Stat reporter Adam Feuerstein on two emerging therapies for spinal muscular atrophy and Duchenne muscular dystrophy.DISCLOSURES: Dr. Ratliff has received speaker honoraria from Teva and US WorldMeds LL...2018-09-1716 minNeurology® PodcastMay 1 2018 Issue1. Featured Article: Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease2. What’s Trending: Drug pricing This Neurology® Podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the May 1, 2018, print issue of Neurology. In the first segment, Dr. Jeff Ratliff talks with Dr. Matthew Barrett about his paper on predictors of psychosis in Parkinson disease. For the “What’s Trending” segment, Dr. Ted Burns discusses drug pricing with journalist Ike Swetlitz.DISCLOSURES: Dr. Ratliff has received a speaker honorarium from Haverford College. Dr. Barrett has received research support from Axovant Sciences, Inc. (cli...2018-04-3021 minNeurology® PodcastMarch 13 2018 Issue1. Featured Article: Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrence2. What’s Trending: Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnosesThis Neurology® Podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the first segment, Dr. Mark McAllister talks with Dr. Luciano Sposato about their paper on the relationship between atrial fibrillation detection and ischemic stroke recurrence. For the “What’s Trending” segment, Dr. Ted Burns speaks with Dr. Mark Keegan and Dr. Nick Zalewski about their paper on idiopathic transverse myelitis and myelo...2018-03-1229 minNeurology® PodcastFebruary 20 2018 Issue1. Featured Article: Intravenous thrombolysis and platelet count2. What’s Trending: Gene Drives, part IThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the February 6, 2018, issue of Neurology. In the first segment, Dr. Kevin Barrett talks with Dr. Henrik Gensicke about his article on the effect of platelet count on bleeding risk and mortality in stroke patients treated with IV thrombolysis. In the second part of the podcast, you’ll hear the first part of Dr. Ted Burns’ interview with Dr. Kevin Esvelt about gene drives.DISCLOSURES: Dr. Barrett serves on the editorial board of Neurol...2018-02-1920 minNeurology® PodcastFebruary 6 2018 IssueFeatured Article: Burnout, Wellness, and the Future of Our ProfessionThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the February 6, 2018, issue of Neurology. This week, Dr. Ted Burns talks with Dr. Terry Cascino about his special address on burnout and the future of neurology. DISCLOSURES: Dr. Burns is the deputy section editor of the Neurology® podcast; has served on scientific advisory boards for Argenx, UCB, and CSL Behring; has received travel funding/speaker honoraria from Argenx and Alexion; and has received support for consulting activities from UCB Pharma and CSL Behring. Dr. Cascino is t...2018-02-0533 minNeurology® PodcastJanuary 2 2018 Issue1) Featured Article: Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy 2) What’s Trending: Clinical Trials in Alzheimer Disease This Neurology® Podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the first segment, Dr. Stacey Clardy talks with Dr. Carlos Pardo about his paper on clinical biomarkers and differential diagnosis of myelitis. For the “What’s Trending” segment, Dr. Ted Burns speaks with journalist Damian Garde about the recent Clinical Trials in Alzheimer Disease conference. DISCLOSURES: Dr. Clardy has received research support from Western Institute for Biomedical Research...2018-01-0128 minNeurology® PodcastDecember 5 2017 IssueShow description/summary:1) Long-term benefit of enzyme-replacement therapy in Pompe disease: A 5-year prospective study2) What’s Trending: ACTH or prednisolone for infantile ataxiaThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the December 5, 2017 issue of Neurology. In the first segment, Dr. Kelly Gwathmey talks with Dr. Nadine van der Beek about her paper on enzyme-replacement therapy in Pompe disease. In the second part of the podcast, Dr. Ted Burns focuses his interview with Dr. John Mytinger on the topic of ACTH or prednisolone for infantile ataxia. DISCLOSURES: Dr. Gwathmey reports no disclosures.Dr. va...2017-12-0419 minNeurology® PodcastNovember 21 2017 IssueShow description/summary:1) Multiparametric MRI changes persist beyond recovery in concussed adolescent hockey players 2) Neurology Today® paper on the increase in gabapentinoid prescriptionThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the November 21, 2017 issue of Neurology. In the first segment, Dr. Ted Burns talks with Dr. Kathryn Manning and Dr. Ravi Menon about their paper regarding the effects of concussion on adolescent hockey players. In the second part of the podcast, Dr. Burns focuses his interview with Dr. Christopher Goodman about a recent Neurology Today article discussing the increase in gabapentinoid prescriptions. Disclosures can b...2017-11-2019 minNeurology® PodcastJuly 25 2017 IssueShow description/summary:1) Neurology and the Humanities: Discovering the patient within2) Topic of the Month: immunosuppressants in neurologyIn the first segment, Dr. Ted Burns talks with Dr. Richard Morton about his Neurology and the Humanities paper, “Discovering the Patient Within.” In the second part of the podcast, Dr. Stacey Clardy focuses her interview with Dr. Anne Cross on immunosuppressants in neurology. Disclosures can be found at Neurology.org.DISCLOSURES:Dr. Burns serves as a section editor for the Neurology® podcast; serves on advisory boards for Argenx, UCB, and CSL Behring; receives travel or speaker honoraria from Argenx and Alexion; and recei...2017-07-2423 minNeurology® PodcastJanuary 10 2017 Issue1) A Randomized, Double-Blind, Placebo-Controlled Trial of Coenzyme Q10 in Huntington's Disease 2) What's Trending: Risk assessment in Duchenne dystrophy3) Topic of the Month: Neuromuscular medicineThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the January 10, 2017 issue of Neurology. In the first segment, Dr. Michelle Fullard talks with Dr. Andrew McGarry about his paper on a randomized trial of coenzyme Q10 in Huntington Disease. Dr. Ted Burns talks with Dr. Sindhu Ramchandren about her Neurology: Genetics paper on Duchenne dystrophy for our “What's Trending” feature of the week. In the next part of the podcast Dr. Ted...2017-01-1026 minNeurology® PodcastOctober 4 20161) Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up2) What's Trending: Interview with Ben Utecht about his recently published book titled: Counting the Days While My Mind Slips Away: A Love Letter to My Family3) Topic of the month: Neurology Today story about NEJM published paper on thymectomy for patients with myasthenia gravisThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Lara Marcuse interviews Dr. Maarten Titulaer about his paper on the clinical features and long-term follow-up of anti-LGI1 encephalitis. Dr. Ted...2016-10-0436 minNeurology® PodcastMay 24 2016 Issue1) Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies2) e-Pearl topic: Neurologic manifestations of hereditary hemorrhagic telangiectasia3) Topic of the month: Neurology Today story about new Center for Disease Control guidelines on prescribing opioids (Part 1)This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Flaherty interviews Dr. Loch Macdonald about his paper on review and meta-analysis of 25 studies about the natural history of cavernous malformation. Dr. Adam Numis is reading our e-Pearl of the week about neurologic...2016-05-2423 minNeurology® PodcastJanuary 29 2013 Issue1) Prolonged anoxic vegetative state and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Flaherty interviews Prof. Luigi Trojano and Dr. Anna Estraneo about their paper on prolonged anoxic vegetative state. Dr. Jen Fugate is reading our e-Pearl of the week about myokymia. In the next part of the podcast Dr. Mike Sowell interviews Dr. Beau Bruce about the topic of pseudotumor cerebri. The participants had nothing to disclose except Drs. Flaherty, Fugate, Bruce...2013-01-2923 min